Cited by — ESR1 and PIK3CA circulating tumor DNA (ctDNA) mutation status as predictive biomarkers beyond variant allele fraction (VAF) in metastatic breast cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite ESR1 and PIK3CA circulating tumor DNA (ctDNA) mutation status as predictive biomarkers beyond variant allele fraction (VAF) in metastatic breast cancer.
No admitted local citation edges point to this work yet.